Corcept Therapeutics saw the highest growth of 1.16% in patent filings in May and 1.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.59% and grants by 1.49%. GlobalData’s DataBook provides a comprehensive analysis of Corcept Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Corcept Therapeutics has been focused on protecting inventions in United States(US) with ten publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 40% filings and 44% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and China(CN) patent Office are among the top ten patent offices where Corcept Therapeutics is filings its patents. Among the top granted patent authorities, Corcept Therapeutics has 44% of its grants in United States(US), 22% in European Patent Office(EPO) and 11% in Australia(AU).

Daiichi Sankyo could be the strongest competitor for Corcept Therapeutics

Corcept Therapeutics stands in second position with respect to its patent publications among its competitors.

Patents related to rare diseases and immuno-oncology lead Corcept Therapeutics's portfolio

Corcept Therapeutics has the highest number of patents in rare diseases followed by, immuno-oncology. For rare diseases, nearly 89% of patents were filed and 100% of patents were granted in Q2 2024.

Cushing's syndrome related patents lead Corcept Therapeutics portfolio followed by fatty liver disease, and steatohepatitis

Corcept Therapeutics has highest number of patents in cushing's syndrome followed by fatty liver disease, steatohepatitis, non alcoholic fatty liver disease (nafld), and hyperglycemia. For cushing's syndrome, nearly 7% of patents were filed and 5% of patents were granted in Q2 2024.

For comprehensive analysis of Corcept Therapeutics's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.